The effects of topical mafenide acetate application on skin graft survival in bacterial contaminated wounds

M Baver Acaban1, Alper Sarı1, Hatice Oruç Demirbağ2

  • 1Plastic, Reconstructive and Aesthetic Surgery Department of Mersin University Medical Faculty, Mersin, Turkey.

Abstract

Insights

Topical Mafenide acetate showed initial graft survival but led to significant cytotoxicity and graft loss in rats by day 14. This study highlights the risks of prolonged use of Mafenide acetate on infected skin grafts.

Area of Science:

  • Wound healing research
  • Dermatology
  • Surgical infection control

Background:

  • Skin graft loss due to infection is a persistent clinical challenge, often inadequately addressed by systemic antibiotics.
  • Mafenide acetate, a topical antimicrobial, penetrates burn eschar and is used for infected full-thickness skin grafts.
  • This study evaluates topical Mafenide acetate's impact on graft survival in a rat model of contaminated wounds.

Purpose of the Study:

  • To investigate the effects of topical Mafenide acetate on skin graft survival.
  • To assess the efficacy and potential cytotoxicity of Mafenide acetate in infected wound beds.

Main Methods:

  • Twenty-eight rats underwent full-thickness skin grafting with Pseudomonas aeruginosa inoculation.
  • Four groups received different dressings: gauze, hydrofiber, Mafenide acetate-soaked hydrofiber, or Mafenide acetate-soaked gauze.
  • Dressing change frequency varied across groups, with Mafenide acetate groups having less frequent changes.

Main Results:

  • Graft survival rates significantly decreased from day 7 to day 14 in Mafenide acetate-treated groups.
  • Histological analysis revealed dermoepidermal junction detachment and collagen disorganization in Mafenide acetate-treated grafts.
  • Mafenide acetate application demonstrated cytotoxicity, leading to reduced graft adhesion and survival.

Conclusions:

  • Topical Mafenide acetate application resulted in higher graft survival on day 7, but this decreased significantly by day 14.
  • Prolonged use (over 7 days) of Mafenide acetate on infected skin grafts in this rat model induces significant cytotoxicity and graft loss.